Five subjects in this group carried mutations in TERT, two subjects had mutations in TERC, and one fulfilled clinical telomere syndrome criteria, a positive history of thrombocytopenia, a family history of pulmonary fibrosis, but no detectable mutation in TERT, TERC or DKC1. This evidence concerns the gene TERT and pulmonary fibrosis.